Search research articles
Contact Us
Filters
Showing results (181-190 of 257) with videos related to
Page
of 26
Sort By:
Cancer Immunology, Immunotherapy : CII
|
September 18, 2007
Clinical impact of HLA class I expression in rectal cancer
Frank M Speetjens, Elza C de Bruin, Hans Morreau, et al.
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology
|
May 30, 2009
Presence of a high amount of stroma and downregulation of SMAD4 predict for worse survival for stage I-II colon cancer patients
Wilma E Mesker, Gerrit-Jan Liefers, Jan M C Junggeburt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 13, 2010
Identification of a quantitative MINT locus methylation profile predicting local regional recurrence of rectal cancer
Michiel F G de Maat, Cornelis J H van de Velde, Anne Benard, et al.
Gastroenterology
|
December 7, 2010
Magnetic resonance imaging surveillance detects early-stage pancreatic cancer in carriers of a p16-Leiden mutation
Hans F A Vasen, Martin Wasser, Anneke van Mil, et al.
BMC Cancer
|
May 7, 2010
Early onset MSI-H colon cancer with MLH1 promoter methylation, is there a genetic predisposition?
Eddy H J van Roon, Marjo van Puijenbroek, Anneke Middeldorp, et al.
International Journal of Cancer
|
May 29, 2008
Prediction of the immunogenic potential of frameshift-mutated antigens in microsatellite instable cancer
Frank M Speetjens, Marjolein M Lauwen, Kees L Franken, et al.
Scandinavian Journal of Gastroenterology
|
June 17, 2016
Identification of familial colorectal cancer and hereditary colorectal cancer syndromes through the Dutch population-screening program: results ofa pilot study
Sanne J H van Erp, Laura W Leicher, Simone D Hennink, et al.
European Journal of Human Genetics : EJHG
|
May 22, 2024
Germline NPAT inactivating variants as cause of hereditary colorectal cancer
Mariona Terradas, Stephanie A Schubert, Julen Viana-Errasti, et al.
Cancer Research
|
December 18, 2003
The CHEK2*1100delC variant acts as a breast cancer risk modifier in non-BRCA1/BRCA2 multiple-case families
Rogier A Oldenburg, Karin Kroeze-Jansema, Jaennelle Kraan, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 7, 2022
The sensitivity of pan-TRK immunohistochemistry in solid tumours: A meta-analysis
Liesbeth M Hondelink, Anne M R Schrader, Golzar Asri Aghmuni, et al.
Page
of 26
Search research articles
Search
Showing results (181-190 of 257) with videos related to
Sort By:
Page
of 26
Cancer Immunology, Immunotherapy : CII
|
September 18, 2007
Clinical impact of HLA class I expression in rectal cancer
Frank M Speetjens, Elza C de Bruin, Hans Morreau, et al.
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology
|
May 30, 2009
Presence of a high amount of stroma and downregulation of SMAD4 predict for worse survival for stage I-II colon cancer patients
Wilma E Mesker, Gerrit-Jan Liefers, Jan M C Junggeburt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 13, 2010
Identification of a quantitative MINT locus methylation profile predicting local regional recurrence of rectal cancer
Michiel F G de Maat, Cornelis J H van de Velde, Anne Benard, et al.
Gastroenterology
|
December 7, 2010
Magnetic resonance imaging surveillance detects early-stage pancreatic cancer in carriers of a p16-Leiden mutation
Hans F A Vasen, Martin Wasser, Anneke van Mil, et al.
BMC Cancer
|
May 7, 2010
Early onset MSI-H colon cancer with MLH1 promoter methylation, is there a genetic predisposition?
Eddy H J van Roon, Marjo van Puijenbroek, Anneke Middeldorp, et al.
International Journal of Cancer
|
May 29, 2008
Prediction of the immunogenic potential of frameshift-mutated antigens in microsatellite instable cancer
Frank M Speetjens, Marjolein M Lauwen, Kees L Franken, et al.
Scandinavian Journal of Gastroenterology
|
June 17, 2016
Identification of familial colorectal cancer and hereditary colorectal cancer syndromes through the Dutch population-screening program: results ofa pilot study
Sanne J H van Erp, Laura W Leicher, Simone D Hennink, et al.
European Journal of Human Genetics : EJHG
|
May 22, 2024
Germline NPAT inactivating variants as cause of hereditary colorectal cancer
Mariona Terradas, Stephanie A Schubert, Julen Viana-Errasti, et al.
Cancer Research
|
December 18, 2003
The CHEK2*1100delC variant acts as a breast cancer risk modifier in non-BRCA1/BRCA2 multiple-case families
Rogier A Oldenburg, Karin Kroeze-Jansema, Jaennelle Kraan, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 7, 2022
The sensitivity of pan-TRK immunohistochemistry in solid tumours: A meta-analysis
Liesbeth M Hondelink, Anne M R Schrader, Golzar Asri Aghmuni, et al.
Page
of 26